Grants for Small businesses - Education

This funding opportunity supports U.S.-based researchers and organizations in developing non-addictive pain relief therapies to combat the opioid crisis, with a focus on advancing preclinical candidates toward clinical trials.

The "NCI National Clinical Trials Network - Network Lead Academic Participating Sites" grant is a funding opportunity from the National Cancer Institute for academic centers to provide scientific leadership and patient recruitment for large-scale, multi-institutional cancer clinical trials, with a focus on treatment trials, rare cancers, and underserved populations, offering up to $1.7 million per year for a six-year project period.

This funding opportunity provides financial support for organizations to develop and implement strategies that improve health equity and reduce health disparities among underserved women and girls, particularly those from racial and ethnic minority backgrounds.

This funding opportunity supports research collaborations focused on improving health outcomes and reducing healthcare disparities related to chronic diseases among U.S. Hispanic/Latino populations and in Latin America.

The City of York's Education, Empowerment & Enhancement (3E) Grant Program is supported by ARPA funds and aims to increase the operating capacity of small businesses. This program is rooted in the city's broader ARPA grant initiatives, which are designed to benefit City of York residents and the community. The alignment with the city's mission is evident in its focus on supporting local businesses, particularly those in Qualified Census Tract (QCT) areas, which the U.S. Treasury recognizes as disproportionately impacted. This strategic focus ensures that grant funds are directed towards areas and populations most in need, contributing to the overall economic resilience and social well-being of the city. The primary target beneficiaries of the 3E Grant Program are small business owners in the City of York who are minorities, women, or people with disabilities. To be eligible, businesses must also earn $500,000 or less in annual gross revenues, be registered, licensed, and in good standing on all City taxes and obligations, and be physically located within a QCT in the City of York. Additionally, no owners should have been convicted of financial crimes within the past three years. The program's impact goals are centered on fostering business growth and stability within these underserved communities by providing resources for education, professional development, and operational enhancements. The program's priorities and focuses are clearly outlined by the "3E's": Education, Empowerment, and Enhancement. Education encompasses classes, certificates, and training for business owners and/or their employees. Empowerment focuses on retreats, workshops, and coaching to build professional development. Enhancement involves improvements to business operations through new software, products, or equipment. These areas represent the core strategies through which the grant intends to address the operational capacity and growth challenges faced by eligible small businesses. Expected outcomes include a measurable increase in the operating capacity of participating small businesses. This can manifest as improved skills through education, enhanced leadership and strategic thinking through empowerment, and increased efficiency or service offerings through operational enhancements. Eligible costs must occur within a year of receiving grant funds, providing a clear timeframe for impact. The program's theory of change posits that by investing in these key areas, the City of York can create a more equitable and robust local economy, particularly for businesses in historically disadvantaged areas, leading to sustained growth and community benefit.

The "CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development" grant aims to fund the early-stage development of treatments to reduce the harmful health effects caused by exposure to toxic chemicals, which could be used in terrorist attacks or accidentally released from industrial sites, with the end goal of producing at least one well-characterized therapeutic candidate.

This funding opportunity supports research institutions and organizations conducting experimental studies with human participants to explore new brain stimulation techniques for treating substance use disorders.

This funding opportunity provides financial support to local businesses and non-profits for community-focused projects that promote public engagement, enhance public spaces, and foster economic growth in Hyattsville.

This funding opportunity supports researchers and organizations in developing advanced tissue-engineered technologies that mimic cancer biology to improve cancer detection, treatment, and prevention.

This funding opportunity provides financial support for organizations to develop and validate digital therapeutic technologies designed to treat substance use disorders, with the goal of achieving FDA authorization.

The Southern STEM Network Grant VI, administered by the Nevada Governor’s Office of Science, Innovation, and Technology (OSIT), aims to support innovative initiatives that help develop an educated, skilled, and diverse STEM workforce in Southern Nevada. Projects should address increased participation in high-quality STEM programs from underserved groups, raise awareness about STEM opportunities, and ensure high-quality STEM education with engaged business partners across all counties, cities, and districts. Funding is available up to $50,000, with applications due by June 28, 2024. Eligible projects include pilot programs, scaling up existing programs, or extending successful initiatives from other regions.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy. The NOFO is intended to support discovery research for the identification of validated hits relevant to health-related outcomes of participating NIH Institutes. Stages of discovery research covered by this NOFO include: 1) assay development for specific biological targets and disease mechanisms relevant to the mission of participating NIH Institutes with the intent to screen for small molecule compounds that show potential as probes for use in advancing knowledge about the known targets, identifying new targets, or as pre-therapeutic leads; 2) screen implementation high throughput target-focused approaches or moderate throughput phenotypic- and fragment-based approaches to identify initial screening hits; 3) hit validation, including implementation of secondary assays that are orthogonal to the primary assay, advanced cheminformatics analysis and initial medicinal chemistry inspection to prioritize the hit set, and follow-up assays to characterize mode and mechanism of action of the validated hits; 4) hit-to-lead optimization, including SAR to optimize target engagement, selectivity and to minimize chemical liabilities, ADME, PK and PD studies, and, if appropriate, in vivo modeling to test efficacy or biological effects.

This funding opportunity supports U.S.-based small businesses in developing innovative, non-addictive therapies and technologies for improved pain management, addressing the opioid crisis through preclinical research and technological advancements.

Public Health – Seattle & King County is offering a grant of $100,000 to $500,000 for projects that support diverse youth mental health providers, particularly those connected to LGBTQIA and BIPOC communities, with the aim of increasing access to mental health resources, improving retention, and supporting diverse providers in King County, Washington.

This funding initiative aims to create lasting partnerships among educational institutions, industries, and workforce agencies in Tennessee to address local skills gaps and ensure that training programs align with the needs of employers.

The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.

This program provides funding to organizations worldwide for innovative projects that use an open-source AI model to address social challenges in areas like economic development and public services.

This grant provides funding for small-scale cancer research projects that can be completed in two years, aimed at supporting innovative studies and methodologies in various areas of cancer research.

This funding opportunity supports researchers working to identify and address health and healthcare disparities affecting sexual and gender minority populations, particularly those from racial/ethnic minority and lower socioeconomic backgrounds.